Epigral Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

43.14

41.55

41.55

41.55

41.55

Share application money

-

-

-

-

-

Preference share capital

-

55.00

110.00

-

-

Reserves & surplus

1,860.39

1,212.54

1,027.62

684.42

431.66

Loan funds

Secured loans

584.58

907.69

766.14

989.36

626.42

Unsecured loans

-

-

-

-

-

Total

2,488.11

2,216.78

1,945.31

1,715.33

1,099.64

Uses of funds

Fixed assets

Gross block

2,937.58

2,384.68

2,310.66

1,468.73

1,421.11

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

699.56

618.04

506.61

400.90

318.80

Net block

2,238.02

1,766.64

1,804.05

1,067.83

1,102.31

Capital work-in-progress

63.89

482.84

158.10

589.25

125.84

Investments

97.14

20.57

20.62

0.05

0.05

Net current assets

Current assets, loans & advances

752.39

524.28

449.48

466.53

220.55

Less : current liabilities & provisions

663.33

577.55

486.94

408.33

349.12

Total net current assets

89.06

-53.27

-37.46

58.20

-128.56

Miscellaneous expenses not written

-

-

-

-

-

Total

2,488.11

2,216.78

1,945.31

1,715.33

1,099.64

Notes:

Book value of unquoted investments

97.14

20.57

20.57

-

0.05

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

279.21

222.10

293.41

242.60

393.53

Number of equity sharesoutstanding (Lacs)

431.41

415.50

415.50

415.50

415.53